Dual benefit from intramuscular interferon-β treatment in a patient with multiple sclerosis and chronic hepatitis-C virus infection

Hepato-Gastroenterology

Volumn 49, Issue 48, 2002, Pages 1686-1687

  Tan, Funda Uysal ^a   Çetinkaya, Hülya ^a   Erden, Esra ^a   Ulkatan, Sedat ^a   Aydin, Nursel ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Hepatitis C; Interferon beta; Treatment

Indexed keywords

AMINOTRANSFERASE; BETA1A INTERFERON; HEPATITIS ANTIBODY; VIRUS RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ATAXIA; BLOOD TRANSFUSION; CASE REPORT; CESAREAN SECTION; CONTROLLED STUDY; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHYLAXIS; SENSORY DYSFUNCTION; SIDE EFFECT; URINE INCONTINENCE; VISUAL DISORDER;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INJECTIONS, INTRAMUSCULAR; INTERFERON-BETA; MULTIPLE SCLEROSIS;

EID: 0036839910     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Villa E, Trande P, Grottola A, Buttafoco P, Rebecchi AM, et al: Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus. Dig Dis Sci 1996; 41(6):1241-1247.
2. Furusyo N, Hayashi J, Ohmiya M, Sawayama Y, Kawakami Y, et al: Differences between interferon-α and β treatment for patients with chronic hepatitis C virus infection. Dig Dis Sci 1999; 44(3):608-617.
3. Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Pellicelli A, et al: Intravenous recombinant interferon-beta versus interferon-alpha-2b and ribavirin in combination for short-term treatment of chronic hepatitis C not responding to interferon-alpha. Scand J Gastroenterol 1999; 9:928-933.
4. Weinstock-Guttman B, Ransohoff RM, Kinkel P, Rudick RA: The interferons: Biological effects, mechanisms of action, and use in multiple sclerosis. Ann Neurol 1995; 37(1):7-15.
5. Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, et al: Intramuscular interferon-beta 1a for disease progression in relapsing multiple sclerosis. Ann Neurol 1996; 39(3):285-294.
6. Stüve O, Dooley NP, Uhm JH, Antel JP, Francis GS, et al: Interferon-beta 1b decreases the migration of T-lymphocytes in vitro: Effects on matrix metalloproteinase-9. Ann Neurol 1996; 40-:853-863.
7. Castro A, Suarez D, Inglada L, Carballo E, Dominguez A, et al: Multicenter randomized, controlled study of intramuscular administration of interferon-β for the treatment of chronic hepatitis C. J Interferon Cytokine Res 1997; 17(1):27-30.
8. Montalto G, Tripi S, Cartabellotta A, Fulco M, Soresi M, et al: Intravenous natural β-interferon in white patients with chronic hepatits C who are nonresponders to α-interferon. Am J Gastroenterol 1998; 93(6):950-953.
9. Terranova R, Luca S: Preliminary results of beta-interferon treatment in the elderly. Control Clin Trials 1996; 17(2):123-129.
10. Fesce E, Airoldi A, Mondazzi L, Maggi C, Gubertini G, et al: Intramuscular beta interferon for chronic hepatitis C: is it worth trying? Ital J Gastroenterol Hepatol 1998; 30(2):185-188.